Oragenics
Tampa
About Oragenics
Oragenics is a development-stage company that primarily engages in fighting infectious diseases, including coronaviruses and multidrug-resistant organisms. Its lead product is an intranasal vaccine candidate to provide long-lasting immunity from SARS-CoV-2 and its variants, which cause COVID-19.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $127.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: nysemkt:OGEN
- Website: oragenics.com
- Phone: (813)286-7900
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oragenics-35026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.